SafeStitch and TransEnterix complete merger
SafeStitch Medical (OTCBB:SFES) and closely-held TransEnterix have completed a previously announced merger, with the combined company to be renamed TransEnterix. The company will continue to trade...
View ArticleTransEnterix readying FDA filing of SurgiBot in mid-year
TransEnterix (NYSE MKT:TRXC) plans to file for FDA approval in mid-year of its SurgiBot robotic platform to enhance minimally invasive laparoscopic surgery through a single surgical incision. Todd Pope...
View ArticleTransEnterix files 510(k) with FDA for SurgiBot
TransEnterix (NYSE MKT:TRXC) has submitted a 510(k) application with the FDA for clearance of the company’s SurgiBot System. Robotically enhanced laparoscopy with the SurgiBot System represents the...
View ArticleTransEnterix names Paul Ziegler as VP sales
TransEnterix (NYSE MKT:TRXC) has appointed Paul Ziegler as VP of sales, effective August 31. He will report directly to CEO, Todd Pope. Paul Ziegler Most recently, Mr. Ziegler served as regional VP of...
View ArticleTransEnterix updates SurgiBot FDA submission
TransEnterix (NYSE MKT:TRXC) has received an update from the FDA on the status of the 510(k) submission for its robotics SurgiBot system to improve minimally invasive surgery. The FDA advised the...
View ArticleFDA rejects TransEnterix SurgiBot submission
The FDA has advised TransEnterix (NYSE MKT:TRXC) that its SurgiBot System does not meet the criteria for substantial equivalence based on the data and information submitted by the company in its 510(k)...
View Article
More Pages to Explore .....